Home
BMRN
BMRN News

Latest BioMarin Pharmaceutical Inc. (BMRN) News on March 29, 2025

5 Historically Cheap Growth Stocks to Buy With Confidence in the Wake of the Nasdaq Correction

Motley Fool

2 days ago

5 Historically Cheap Growth Stocks to Buy With Confidence in the Wake of the Nasdaq Correction

2 Reasons to Like BMRN (and 1 Not So Much)

StockStory

3 days ago

2 Reasons to Like BMRN (and 1 Not So Much)

Is BioMarin Pharmaceutical Inc. (BMRN) a Promising Biotech Stock According to Wall Street Analysts

Insider Monkey

3 days ago

Is BioMarin Pharmaceutical Inc. (BMRN) a Promising Biotech Stock According to Wall Street Analysts

Argus Research

4 days ago

BMRN: What does Argus have to say about BMRN?

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

StockStory

5 days ago

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue?

Zacks

8 days ago

BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue?

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

Zacks

8 days ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

StockStory

8 days ago

Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)

BioMarin Pharmaceutical (BMRN): Among Paul Singer’s Latest Portfolio’s Top Stock Picks

Insider Monkey

9 days ago

BioMarin Pharmaceutical (BMRN): Among Paul Singer’s Latest Portfolio’s Top Stock Picks

BioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinical Practice with VOXZOGO® (vosoritide) in Children Under 3 with Achondroplasia at 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

PR Newswire

9 days ago

BioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinical Practice with VOXZOGO® (vosoritide) in Children Under 3 with Achondroplasia at 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

StockStory

9 days ago

Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

StockStory

10 days ago

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?

Zacks

11 days ago

BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?

Is BioMarin Pharmaceutical (BMRN) the Best Biotech Stock According to Billionaires?

Insider Monkey

11 days ago

Is BioMarin Pharmaceutical (BMRN) the Best Biotech Stock According to Billionaires?

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Zacks

12 days ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies

Zacks

12 days ago

AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies

Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks

17 days ago

Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"

Wall Street Analysts Believe BioMarin (BMRN) Could Rally 36.57%: Here's is How to Trade

Zacks

17 days ago

Wall Street Analysts Believe BioMarin (BMRN) Could Rally 36.57%: Here's is How to Trade

Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-Term

Zacks

17 days ago

Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-Term

PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study

Zacks

18 days ago

PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study

1 Healthcare Stock to Target This Week and 2 to Turn Down

StockStory

18 days ago

1 Healthcare Stock to Target This Week and 2 to Turn Down

Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

StockStory

18 days ago

Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

4 Discounted PEG Stocks Offering the Best Returns to Value Investors

Zacks

19 days ago

4 Discounted PEG Stocks Offering the Best Returns to Value Investors

Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait?

Zacks

21 days ago

Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait?

Scoop Up These 4 Stocks With Amazing Interest Coverage Ratio

Zacks

23 days ago

Scoop Up These 4 Stocks With Amazing Interest Coverage Ratio

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term

Zacks

24 days ago

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term

Argus Research

25 days ago

BMRN: Rating increased to a HOLD

Statutory Profit Doesn't Reflect How Good BioMarin Pharmaceutical's (NASDAQ:BMRN) Earnings Are

Simply Wall St.

25 days ago

Statutory Profit Doesn't Reflect How Good BioMarin Pharmaceutical's (NASDAQ:BMRN) Earnings Are

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

StockStory

25 days ago

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

Is Auna S.A. (AUNA) Stock Outpacing Its Medical Peers This Year?

Zacks

a month ago

Is Auna S.A. (AUNA) Stock Outpacing Its Medical Peers This Year?

BMRN or CSLLY: Which Is the Better Value Stock Right Now?

Zacks

a month ago

BMRN or CSLLY: Which Is the Better Value Stock Right Now?

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

Zacks

a month ago

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

Biotech Stock Roundup: BLUE Down on Update, News From GILD, TRDA

Zacks

a month ago

Biotech Stock Roundup: BLUE Down on Update, News From GILD, TRDA

Results: BioMarin Pharmaceutical Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Simply Wall St.

a month ago

Results: BioMarin Pharmaceutical Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Argus Research

a month ago

BMRN: Raising target price to $57.00

BioMarin to Present at the TD Cowen 45th Annual Healthcare Conference on Tuesday, March 4 at 6:50 AM PT / 9:50 AM ET in Boston, MA

PR Newswire

a month ago

BioMarin to Present at the TD Cowen 45th Annual Healthcare Conference on Tuesday, March 4 at 6:50 AM PT / 9:50 AM ET in Boston, MA

Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect

StockStory

a month ago

Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect

What To Expect From United Therapeutics’s (UTHR) Q4 Earnings

StockStory

a month ago

What To Expect From United Therapeutics’s (UTHR) Q4 Earnings

BioMarin Announces Appointment of Timothy P. Walbert to Board of Directors

PR Newswire

a month ago

BioMarin Announces Appointment of Timothy P. Walbert to Board of Directors

BioMarin (BMRN) is an Incredible Growth Stock: 3 Reasons Why

Zacks

a month ago

BioMarin (BMRN) is an Incredible Growth Stock: 3 Reasons Why

Investing.com

a month ago

Oppenheimer upgrades BioMarin on long term outlook

Does BioMarin (BMRN) Have the Potential to Rally 40.54% as Wall Street Analysts Expect?

Zacks

a month ago

Does BioMarin (BMRN) Have the Potential to Rally 40.54% as Wall Street Analysts Expect?

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

a month ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

MT Newswires

a month ago

Oppenheimer Upgrades BioMarin Pharmaceutical to Outperform From Market Perform, Price Target is $98

BioMarin price target raised to $80 from $78 at Scotiabank

TipRanks

a month ago

BioMarin price target raised to $80 from $78 at Scotiabank

BioMarin Pharmaceutical Full Year 2024 Earnings: Beats Expectations

Simply Wall St.

a month ago

BioMarin Pharmaceutical Full Year 2024 Earnings: Beats Expectations

Pfizer stops selling hemophilia gene therapy, citing weak demand

BioPharma Dive

a month ago

Pfizer stops selling hemophilia gene therapy, citing weak demand

Why BioMarin Pharmaceutical Stock Zoomed Almost 5% Higher Today

Motley Fool

a month ago

Why BioMarin Pharmaceutical Stock Zoomed Almost 5% Higher Today

Morningstar Research

a month ago

Analyst Report: BioMarin Pharmaceutical Inc.

Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

StockStory

a month ago

Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

MT Newswires

a month ago

UBS Adjusts Price Target on BioMarin Pharmaceutical to $113 From $109, Maintains Buy Rating

Why Is BioMarin Stock Trading Higher On Thursday?

Benzinga

a month ago

Why Is BioMarin Stock Trading Higher On Thursday?

BioMarin Q4 Earnings & Sales Top Estimates, Stock Up on Upbeat '25 View

Zacks

a month ago

BioMarin Q4 Earnings & Sales Top Estimates, Stock Up on Upbeat '25 View

Thomson Reuters StreetEvents

a month ago

Q4 2024 BioMarin Pharmaceutical Inc Earnings Call

Biomarin Pharmaceutical Inc (BMRN) Q4 2024 Earnings Call Highlights: Record Growth and ...

GuruFocus.com

a month ago

Biomarin Pharmaceutical Inc (BMRN) Q4 2024 Earnings Call Highlights: Record Growth and ...

Compared to Estimates, BioMarin (BMRN) Q4 Earnings: A Look at Key Metrics

Zacks

a month ago

Compared to Estimates, BioMarin (BMRN) Q4 Earnings: A Look at Key Metrics

BioMarin Pharmaceutical (BMRN) Surpasses Q4 Earnings and Revenue Estimates

Zacks

a month ago

BioMarin Pharmaceutical (BMRN) Surpasses Q4 Earnings and Revenue Estimates

Associated Press Finance

a month ago

BioMarin: Q4 Earnings Snapshot

BioMarin Pharmaceutical (NASDAQ:BMRN) Reports Bullish Q4, Stock Soars

StockStory

a month ago

BioMarin Pharmaceutical (NASDAQ:BMRN) Reports Bullish Q4, Stock Soars

MT Newswires

a month ago

BioMarin Pharmaceutical Q4 Non-GAAP Earnings, Revenue Rise; 2025 Outlook Set -- Shares Up After Hours

What To Expect From BioMarin Pharmaceutical’s (BMRN) Q4 Earnings

StockStory

a month ago

What To Expect From BioMarin Pharmaceutical’s (BMRN) Q4 Earnings

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Zacks

a month ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

Zacks

a month ago

Will These 5 Biotech Stocks Surpass Q4 Earnings Forecast?

BioMarin to Report Q4 Earnings: Here's What to Expect

Zacks

a month ago

BioMarin to Report Q4 Earnings: Here's What to Expect

SpringWorks Therapeutics (SWTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

a month ago

SpringWorks Therapeutics (SWTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Unveiling BioMarin (BMRN) Q4 Outlook: Wall Street Estimates for Key Metrics

Zacks

a month ago

Unveiling BioMarin (BMRN) Q4 Outlook: Wall Street Estimates for Key Metrics

BMRN vs. CSLLY: Which Stock Is the Better Value Option?

Zacks

a month ago

BMRN vs. CSLLY: Which Stock Is the Better Value Option?

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

a month ago

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

a month ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Why BioMarin Pharmaceutical Inc. (BMRN) Is Among the Best Healthcare Stocks To Buy According to Analysts

Insider Monkey

2 months ago

Why BioMarin Pharmaceutical Inc. (BMRN) Is Among the Best Healthcare Stocks To Buy According to Analysts

3 Reasons Growth Investors Will Love BioMarin (BMRN)

Zacks

2 months ago

3 Reasons Growth Investors Will Love BioMarin (BMRN)

BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET

PR Newswire

2 months ago

BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET

Zacks.com featured highlights BioMarin, Cheesecake Factory, Leidos and The Ensign

Zacks

2 months ago

Zacks.com featured highlights BioMarin, Cheesecake Factory, Leidos and The Ensign

Argus Research

2 months ago

BMRN: Rating increased to a HOLD

Tasso and Arup to develop blood testing services for clinical research

Medical Device Network

2 months ago

Tasso and Arup to develop blood testing services for clinical research

4 Stocks That Sport Impressive Interest Coverage Ratio

Zacks

2 months ago

4 Stocks That Sport Impressive Interest Coverage Ratio

Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?

Zacks

2 months ago

Will Non-COVID Drugs Drive PFE's Top Line in Q4 Earnings?

MT Newswires

2 months ago

BofA Adjusts Price Target on BioMarin Pharmaceutical to $99 From $100

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Zacks

2 months ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Argus Research

2 months ago

BMRN: Raising target price to $51.00

FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication

Zacks

2 months ago

FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication

Is BioMarin Pharmaceutical (BMRN) the Best Depressed Stock to Invest in Now?

Insider Monkey

2 months ago

Is BioMarin Pharmaceutical (BMRN) the Best Depressed Stock to Invest in Now?

BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?

Zacks

2 months ago

BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?

NVO Stock Rises as New Obesity Drug Shows Superior Weight Loss

Zacks

2 months ago

NVO Stock Rises as New Obesity Drug Shows Superior Weight Loss

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Zacks

2 months ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Why Is Andreas Halvorsen Bullish On BioMarin Pharmaceutical Inc. (BMRN) Now?

Insider Monkey

2 months ago

Why Is Andreas Halvorsen Bullish On BioMarin Pharmaceutical Inc. (BMRN) Now?

Zacks.com featured highlights include BioMarin, Amazon.com, Leidos and The Ensign

Zacks

2 months ago

Zacks.com featured highlights include BioMarin, Amazon.com, Leidos and The Ensign

These 4 Stocks Boast Impressive Interest Coverage Ratio

Zacks

2 months ago

These 4 Stocks Boast Impressive Interest Coverage Ratio

Argus Research

2 months ago

BMRN: Lowering target price to $50.00

Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study

Zacks

2 months ago

Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study

Earnings are growing at BioMarin Pharmaceutical (NASDAQ:BMRN) but shareholders still don't like its prospects

Simply Wall St.

2 months ago

Earnings are growing at BioMarin Pharmaceutical (NASDAQ:BMRN) but shareholders still don't like its prospects

BioMarin Pharmaceutical Inc. (BMRN) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025

Insider Monkey

2 months ago

BioMarin Pharmaceutical Inc. (BMRN) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025

Here is Why Growth Investors Should Buy BioMarin (BMRN) Now

Zacks

2 months ago

Here is Why Growth Investors Should Buy BioMarin (BMRN) Now

Zacks Industry Outlook Highlights Incyte, BioMarin, Exelixis, Halozyme and Blueprint Medicines

Zacks

2 months ago

Zacks Industry Outlook Highlights Incyte, BioMarin, Exelixis, Halozyme and Blueprint Medicines

Argus Research

2 months ago

BMRN: Lowering target price to $51.00

5 Biotech Stocks Worth Adding to Your Portfolio in 2025

Zacks

2 months ago

5 Biotech Stocks Worth Adding to Your Portfolio in 2025

MT Newswires

3 months ago

BioMarin Pharmaceutical Sues Ascendis Pharma for Alleged Patent Infringement in Germany

BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court

PR Newswire

3 months ago

BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court

Wall Street Analysts Predict a 45.86% Upside in BioMarin (BMRN): Here's What You Should Know

Zacks

3 months ago

Wall Street Analysts Predict a 45.86% Upside in BioMarin (BMRN): Here's What You Should Know

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

Zacks

3 months ago

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock

Share on Social Networks: